IL164523A0 - Cytokine receptor - Google Patents
Cytokine receptorInfo
- Publication number
- IL164523A0 IL164523A0 IL16452304A IL16452304A IL164523A0 IL 164523 A0 IL164523 A0 IL 164523A0 IL 16452304 A IL16452304 A IL 16452304A IL 16452304 A IL16452304 A IL 16452304A IL 164523 A0 IL164523 A0 IL 164523A0
- Authority
- IL
- Israel
- Prior art keywords
- polypeptide
- seq
- amino acids
- level
- sample
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37381302P | 2002-04-19 | 2002-04-19 | |
PCT/US2003/012030 WO2003089603A2 (en) | 2002-04-19 | 2003-04-18 | Cytokine receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164523A0 true IL164523A0 (en) | 2005-12-18 |
Family
ID=29251089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16452304A IL164523A0 (en) | 2002-04-19 | 2004-10-12 | Cytokine receptor |
Country Status (13)
Country | Link |
---|---|
US (7) | US20040029228A1 (de) |
EP (2) | EP2295455A1 (de) |
JP (2) | JP4409962B2 (de) |
CN (2) | CN1659274A (de) |
AT (1) | ATE493438T1 (de) |
AU (2) | AU2003225055B2 (de) |
BR (1) | BR0309401A (de) |
CA (1) | CA2482368A1 (de) |
DE (1) | DE60335536D1 (de) |
ES (1) | ES2356307T3 (de) |
IL (1) | IL164523A0 (de) |
RU (1) | RU2004133765A (de) |
WO (1) | WO2003089603A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004532611A (ja) * | 2000-11-28 | 2004-10-28 | ザイモジェネティクス,インコーポレイティド | サイトカイン受容体zcytor19 |
TW200300170A (en) * | 2001-11-09 | 2003-05-16 | Wyeth Corp | Type 2 cytokine receptor and nucleic acids encoding same |
AU2003215136A1 (en) * | 2002-02-08 | 2003-09-02 | University Of Medicine And Dentistry Of New Jersey | Ifn-a/b-independent mechanism of antiviral protection |
JP4409962B2 (ja) * | 2002-04-19 | 2010-02-03 | ザイモジェネティクス,インコーポレイティド | サイトカイン受容体 |
JP2006509041A (ja) | 2002-10-23 | 2006-03-16 | ザイモジェネティクス,インコーポレイティド | Il−28およびil−29を用いるウイルス感染を治療するための方法 |
DK1668031T3 (da) | 2003-08-07 | 2008-06-30 | Zymogenetics Inc | Homogene præparater af IL-29 |
US20050244423A1 (en) * | 2004-04-02 | 2005-11-03 | Klucher Kevin M | Methods for treating viral infection using IL-28 and IL-29 cysteine mutants |
US7351689B2 (en) * | 2004-07-29 | 2008-04-01 | Zymogenetics, Inc. | Use of IL-28 and IL-29 to treat cancer and autoimmune disorders |
JP4987001B2 (ja) * | 2005-07-20 | 2012-07-25 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | 癌および自己免疫障害を処置するためのil28およびil29の短縮型システイン変異体の使用法 |
JP2009502803A (ja) * | 2005-07-20 | 2009-01-29 | ザイモジェネティクス, インコーポレイテッド | Il−28およびil−29のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法 |
WO2013103981A1 (en) * | 2012-01-06 | 2013-07-11 | Ember Therapeutics, Inc. | Compositions and methods of use of fndc5 polypeptides |
EP2617732A1 (de) * | 2012-01-19 | 2013-07-24 | Vib Vzw | Werkzeuge und Verfahren zur Expression von Membranproteinen |
GB201514875D0 (en) * | 2015-08-20 | 2015-10-07 | Autolus Ltd | Receptor |
AU2016369490C1 (en) | 2015-12-18 | 2021-12-23 | Sangamo Therapeutics, Inc. | Targeted disruption of the T cell receptor |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US846A (en) | 1838-07-17 | Improvement in revolving fire-arms | ||
US5738A (en) | 1848-08-29 | Francis kelsey | ||
DK368882A (da) | 1981-08-25 | 1983-02-26 | Alan John Kingsman | Expessions vektorer |
US4579821A (en) | 1981-11-23 | 1986-04-01 | University Patents, Inc. | Control of DNA sequence transcription |
US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
US4486533A (en) | 1982-09-02 | 1984-12-04 | St. Louis University | Filamentous fungi functional replicating extrachromosomal element |
US4599311A (en) | 1982-08-13 | 1986-07-08 | Kawasaki Glenn H | Glycolytic promotersfor regulated protein expression: protease inhibitor |
US4977092A (en) | 1985-06-26 | 1990-12-11 | Amgen | Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
US4661454A (en) | 1983-02-28 | 1987-04-28 | Collaborative Research, Inc. | GAL1 yeast promoter linked to non galactokinase gene |
US5139936A (en) | 1983-02-28 | 1992-08-18 | Collaborative Research, Inc. | Use of the GAL1 yeast promoter |
US4624846A (en) | 1983-07-29 | 1986-11-25 | Immunomedics, Inc. | Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles |
US4870008A (en) | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
US4931373A (en) | 1984-05-25 | 1990-06-05 | Zymogenetics, Inc. | Stable DNA constructs for expression of α-1 antitrypsin |
US4766073A (en) | 1985-02-25 | 1988-08-23 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
DE3578435D1 (de) | 1984-12-06 | 1990-08-02 | Labofina Sa | Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden. |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
US4882279A (en) | 1985-10-25 | 1989-11-21 | Phillips Petroleum Company | Site selective genomic modification of yeast of the genus pichia |
US4935349A (en) | 1986-01-17 | 1990-06-19 | Zymogenetics, Inc. | Expression of higher eucaryotic genes in aspergillus |
US5057313A (en) | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
GB8611832D0 (en) | 1986-05-15 | 1986-06-25 | Holland I B | Polypeptide |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5055291A (en) | 1986-11-04 | 1991-10-08 | Baylor College Of Medicine | Compositions for preventing secondary cataracts |
US5063154A (en) | 1987-06-24 | 1991-11-05 | Whitehead Institute For Biomedical Research | Pheromone - inducible yeast promoter |
ES2092468T3 (es) | 1988-01-22 | 1996-12-01 | Zymogenetics Inc | Metodos para producir analogos de receptores secretados. |
US5567584A (en) | 1988-01-22 | 1996-10-22 | Zymogenetics, Inc. | Methods of using biologically active dimerized polypeptide fusions to detect PDGF |
US5529932A (en) | 1988-01-28 | 1996-06-25 | Pharmacia, S.P.A. | Isolated DNA encoding a plant ribosome inactivating protein from the leaves of saponaria officinalis |
US5120525A (en) | 1988-03-29 | 1992-06-09 | Immunomedics, Inc. | Radiolabeled antibody cytotoxic therapy of cancer |
US4956288A (en) | 1988-04-22 | 1990-09-11 | Biogen, Inc. | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA |
US5037743A (en) | 1988-08-05 | 1991-08-06 | Zymogenetics, Inc. | BAR1 secretion signal |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5162228A (en) | 1988-12-28 | 1992-11-10 | Takeda Chemical Industries, Ltd. | Gylceraldehyde-3-phosphate dehydrogenase gene and promoter |
US5576288A (en) | 1989-04-27 | 1996-11-19 | The Salk Institute For Biological Studies | Fibroblast growth factor conjugates |
US5191067A (en) | 1989-04-27 | 1993-03-02 | The Salk Institute For Biological Studies | Fibroblast growth factor conjugates |
US5162222A (en) | 1989-07-07 | 1992-11-10 | Guarino Linda A | Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses |
US5635384A (en) | 1990-06-11 | 1997-06-03 | Dowelanco | Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using |
US5478804A (en) | 1990-09-19 | 1995-12-26 | The Salk Institute For Biological Studies | Treatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugates |
IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
JPH06504438A (ja) | 1990-12-13 | 1994-05-26 | イミュネックス・コーポレーション | 白血病抑制因子受容体 |
US5298418A (en) | 1991-09-16 | 1994-03-29 | Boyce Thompson Institute For Plant Research, Inc. | Cell line isolated from larval midgut tissue of Trichoplusia ni |
US5382657A (en) | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
WO1994006463A1 (en) | 1992-09-14 | 1994-03-31 | Pfizer Inc | Immortalized cells and uses therefor |
WO1994020540A1 (es) | 1993-03-02 | 1994-09-15 | Universidad De Valladolid | PROTEINAS INACTIVADORAS DE RIBOSOMAS (RIPs) DE DOS CADENAS NO TOXICAS, PROCEDIMIENTO PARA SU PREPARACION Y APLICACIONES |
CA2171192A1 (en) | 1993-09-06 | 1995-03-16 | Fiorenzo Stirpe | Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them |
US5443953A (en) | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
WO1995021930A2 (en) | 1994-02-14 | 1995-08-17 | Zymogenetics, Inc. | Method for preparing orphan receptor ligands |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5911995A (en) | 1994-08-19 | 1999-06-15 | Regents Of The University Of Minnesota | EGF-genistein conjugates for the treatment of cancer |
US5738846A (en) | 1994-11-10 | 1998-04-14 | Enzon, Inc. | Interferon polymer conjugates and process for preparing the same |
WO1997017450A2 (en) | 1995-11-09 | 1997-05-15 | Zymogenetics, Inc. | Compositions and methods for producing heterologous polypeptides in pichia methanolica |
IT1286663B1 (it) | 1996-06-27 | 1998-07-15 | Ministero Uni Ricerca Scient E | Proteina capace di inibire l'attivita' ribosomiale,sua preparazione ed uso come immunoconiugato chimico o ricombinante e sequenza di cdna |
IL128073A0 (en) | 1996-07-17 | 1999-11-30 | Zymogenetics Inc | Transformation of pichia methanolica |
JP2002514049A (ja) | 1996-07-17 | 2002-05-14 | ザイモジェネティクス,インコーポレイティド | ピヒア・メタノリカの栄養要求性突然変異体の製造 |
CA2273194C (en) | 1996-12-03 | 2011-02-01 | Abgenix, Inc. | Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
US5945511A (en) | 1997-02-20 | 1999-08-31 | Zymogenetics, Inc. | Class II cytokine receptor |
AU8040898A (en) | 1997-06-06 | 1998-12-21 | Tanox Pharma B.V. | Type-1 ribosome-inactivating protein |
US5965704A (en) | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
EP1131333B1 (de) | 1998-10-26 | 2010-06-02 | Wyeth a Corporation of the State of Delaware | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung |
AU6069300A (en) | 1999-07-02 | 2001-01-22 | Chiron Corporation | Novel human genes and gene expression products |
CN100448993C (zh) | 2000-06-30 | 2009-01-07 | 津莫吉尼蒂克斯公司 | 干扰素样蛋白质Zcyto21 |
DE10031389A1 (de) * | 2000-07-03 | 2002-01-17 | Knoll Ag | Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie |
JP2004509617A (ja) * | 2000-09-08 | 2004-04-02 | シェーリング コーポレイション | 哺乳動物遺伝子;関連試薬および方法 |
JP2004532611A (ja) * | 2000-11-28 | 2004-10-28 | ザイモジェネティクス,インコーポレイティド | サイトカイン受容体zcytor19 |
CN100482684C (zh) * | 2001-04-20 | 2009-04-29 | 津莫吉尼蒂克斯公司 | 细胞因子蛋白质家族 |
EP1439223A1 (de) | 2001-10-02 | 2004-07-21 | Mochida Pharmaceutical Co., Ltd. | Neuer klasse-ii-cytokinrezeptor |
TW200300170A (en) | 2001-11-09 | 2003-05-16 | Wyeth Corp | Type 2 cytokine receptor and nucleic acids encoding same |
US7033787B2 (en) * | 2001-12-21 | 2006-04-25 | Ludwig Institute For Cancer Research | Isolated cytokine receptor LICR-2 |
AU2003215136A1 (en) | 2002-02-08 | 2003-09-02 | University Of Medicine And Dentistry Of New Jersey | Ifn-a/b-independent mechanism of antiviral protection |
JP4409962B2 (ja) * | 2002-04-19 | 2010-02-03 | ザイモジェネティクス,インコーポレイティド | サイトカイン受容体 |
JP2006509041A (ja) * | 2002-10-23 | 2006-03-16 | ザイモジェネティクス,インコーポレイティド | Il−28およびil−29を用いるウイルス感染を治療するための方法 |
JP2009520459A (ja) * | 2003-02-14 | 2009-05-28 | サイグレス ディスカバリー, インコーポレイテッド | 癌における治療標的 |
-
2003
- 2003-04-18 JP JP2003586316A patent/JP4409962B2/ja not_active Expired - Fee Related
- 2003-04-18 CN CN03812713.XA patent/CN1659274A/zh active Pending
- 2003-04-18 DE DE60335536T patent/DE60335536D1/de not_active Expired - Lifetime
- 2003-04-18 EP EP10180287A patent/EP2295455A1/de not_active Withdrawn
- 2003-04-18 AU AU2003225055A patent/AU2003225055B2/en not_active Ceased
- 2003-04-18 AT AT03721762T patent/ATE493438T1/de not_active IP Right Cessation
- 2003-04-18 CA CA002482368A patent/CA2482368A1/en not_active Abandoned
- 2003-04-18 BR BRPI0309401-4A patent/BR0309401A/pt unknown
- 2003-04-18 WO PCT/US2003/012030 patent/WO2003089603A2/en active Application Filing
- 2003-04-18 US US10/420,034 patent/US20040029228A1/en not_active Abandoned
- 2003-04-18 CN CN200910175119A patent/CN101676728A/zh active Pending
- 2003-04-18 ES ES03721762T patent/ES2356307T3/es not_active Expired - Lifetime
- 2003-04-18 RU RU2004133765/13A patent/RU2004133765A/ru not_active Application Discontinuation
- 2003-04-18 EP EP03721762A patent/EP1497415B1/de not_active Expired - Lifetime
-
2004
- 2004-10-12 IL IL16452304A patent/IL164523A0/xx unknown
-
2006
- 2006-10-09 US US11/539,789 patent/US20070264685A1/en not_active Abandoned
- 2006-10-09 US US11/539,816 patent/US20070134727A1/en not_active Abandoned
- 2006-10-09 US US11/539,780 patent/US7723298B2/en not_active Expired - Lifetime
- 2006-10-09 US US11/539,841 patent/US20070048847A1/en not_active Abandoned
-
2009
- 2009-07-23 AU AU2009203007A patent/AU2009203007A1/en not_active Abandoned
- 2009-07-24 JP JP2009172922A patent/JP2009268469A/ja not_active Ceased
-
2010
- 2010-03-12 US US12/723,364 patent/US20110171627A1/en not_active Abandoned
-
2011
- 2011-10-04 US US13/252,723 patent/US20120053321A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1497415A2 (de) | 2005-01-19 |
CA2482368A1 (en) | 2003-10-30 |
US20120053321A1 (en) | 2012-03-01 |
JP2006504401A (ja) | 2006-02-09 |
ATE493438T1 (de) | 2011-01-15 |
US20040029228A1 (en) | 2004-02-12 |
EP2295455A1 (de) | 2011-03-16 |
CN101676728A (zh) | 2010-03-24 |
ES2356307T3 (es) | 2011-04-06 |
AU2003225055B2 (en) | 2009-04-23 |
WO2003089603A3 (en) | 2004-09-16 |
US7723298B2 (en) | 2010-05-25 |
CN1659274A (zh) | 2005-08-24 |
US20070048847A1 (en) | 2007-03-01 |
US20110171627A1 (en) | 2011-07-14 |
US20070264685A1 (en) | 2007-11-15 |
BR0309401A (pt) | 2007-02-21 |
WO2003089603A2 (en) | 2003-10-30 |
AU2009203007A1 (en) | 2009-08-13 |
EP1497415B1 (de) | 2010-12-29 |
RU2004133765A (ru) | 2005-06-27 |
AU2003225055A1 (en) | 2003-11-03 |
US20070134727A1 (en) | 2007-06-14 |
EP1497415A4 (de) | 2006-03-22 |
JP4409962B2 (ja) | 2010-02-03 |
DE60335536D1 (de) | 2011-02-10 |
US20070122879A1 (en) | 2007-05-31 |
JP2009268469A (ja) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL164523A0 (en) | Cytokine receptor | |
DE69331550D1 (de) | Klonierung und expression von biologisch aktiver alpha-galaktosidase a | |
FI107610B (fi) | HCV-fuusioproteiini | |
IL210455A (en) | A polypeptide for reducing mammalian signaling 13il, and using a polypeptide to produce a drug for up-regulating gene expression 2ra13-il in mammals | |
SI0935660T1 (sl) | Infekcijski kloni RNA virusov ter cepiva in diagnostični testi, izvedeni iz le-teh | |
IL145288A (en) | Isolated cytokine zalpha11 ligand polypeptide and uses thereof | |
BG101408A (en) | Analogs of keratinocyte growth factor | |
AU2002307510A1 (en) | Cytokine protein family | |
MY135991A (en) | A vaccine-induced hepatits b viral strain and uses thereof | |
DK0388963T3 (da) | Fremgangsmåde til ekspression af et rekombinant gen | |
AU4765099A (en) | Method of genetic modification of a wild type viral sequence | |
DK0828004T3 (da) | Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær | |
EP1074624A4 (de) | Gen 62 des attenuierten windpocken-virusstammes okaund verfahren zur identifikation eines attenuierten, lebenden windpockenvirusstammes unter verwendung dieses genes. | |
EP0949333A4 (de) | Mutierte antigene des masernvirus und die dafür kodierenden gene. | |
WO2003054010A3 (en) | Early stage redox-related apoptosis modulator-2 (esram-2) |